Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Dec 4;10(12):488. doi: 10.3390/cancers10120488

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Overall survival (OS), progression-free survival (PFS), and local disease-free survival (LDFS) of 67 patients treated with curative intent for minor salivary gland adenoid cystic carcinoma with not significant difference between T-stages (T1–4). (a) Death during follow up, T1: o/6 patients (0%), T2: 2/5 patients (40%), T3:2/12 patients (16.7%), T4: 6/44 patients (13.6%). (b) Progression of disease during follow up (local and distant), T1: o/6 patients (0%), T2: 2/5 patients (40%), T3: 3/12 patients (25%), T4: 15/44 patients (34.1%). (c) Local recurrence during follow up, T1: o/6 patients (0%), T2: 0/5 patients (0%), T3: 2/12 patients 16.7%), T4: 9/44 patients (20.5%). Abbreviations: overall survival (OS), progression-free survival (PFS), local disease-free survival (LDFS).